EXPLANATORY NOTE

(This note is not part of the Order)

This Order amends the Export Control Order 2008 (S.I. 2008/3231). Article 2 introduces a new control on the export of pharmaceutical goods for human use containing the active ingredient thiopental sodium to the United States of America and makes other related amendments. This Order will cease to have effect on 28 November 2011.

The Explanatory Memorandum is available alongside the instrument on the OPSI website. The Impact Assessment is currently being prepared.